Louisiana State Employees Retirement System’s Tvardi Therapeutics TVRD Stock Holding History

Louisiana State Employees Retirement System’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-583	Closed	-$103K	–	1533
2023 Q1	$103K	Sell	583 -11	-2%	-$3.68K	﹤0.01%	1500
2022 Q4	$230K	Sell	594 -6	-1%	-$2.28K	0.01%	1455
2022 Q3	$202K	Buy	600 +31	+5%	+$11.2K	0.01%	1458
2022 Q2	$197K	Buy	569 +2	+0.4%	+$702	0.01%	1479
2022 Q1	$267K	Hold	567	–	–	0.01%	1463
2021 Q4	$248K	Buy	567 +3	+0.5%	+$1.51K	0.01%	1481
2021 Q3	$314K	Buy	564 +25	+5%	+$12.5K	0.01%	1440
2021 Q2	$277K	Buy	+539	New	+$342K	0.01%	1451

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Louisiana State Employees Retirement System's TVRD Position: Q2 2023 in Review

Louisiana State Employees Retirement System sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 583 shares — an estimated $103K sold.

Louisiana State Employees Retirement System first reported a position in TVRD in Q2 2021 and held it in 8 quarters. The position peaked at $314K in Q3 2021. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

Louisiana State Employees Retirement System reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
Louisiana State Employees Retirement System sold 583 Tvardi Therapeutics shares in Q2 2023, an estimated $103K.
Louisiana State Employees Retirement System first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 8 quarters.
Louisiana State Employees Retirement System's Tvardi Therapeutics position peaked at $314K in Q3 2021.
137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2023, filed 18 Jul 2023.